All clinical trials at Mercy are centrally managed by Mercy Research to ensure compliance and quality throughout our health system. We have over 700 active studies with more than 4,000 participating patients across five states.
Mercy advocates the advancement of new and better medical treatments for our patients. We offer clinical trials in most specialty areas, including oncology, ophthalmology, cardiology, neurology and neurosurgery, gastroenterology, endocrinology, infectious disease and pain management. Clinical Studies offer our patients earlier access to new treatments, frequent monitoring through more visits with the provider, active participation in their own care, participation in a medical breakthrough and more options which means more HOPE.
Through our integrated and unified model, we offer our sponsors the full resources of the 10th largest health System in the U.S., personalized study management, excellence in Quality and Compliance, low deviations rates and efficient enrollment.
Mercy is the first and only large institution in the US with the ability to roll-out a trial to multiple states and multiple internal PIs, while only negotiating one contract and one budget. All regulatory is overseen by one internal IRB and can be approved in as little as 45 days. Mercy is also the only institution of its size that has vertically integrated and centralized its legal, compliance and recruiting under a single unified leadership structure.